Sleep Disorders Pharmaceutical and Healthcare Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Sleep Disorders Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the pipeline landscape for sleep disorders. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for Restless Legs Syndrome, Nocturia and Insomnia, and features dormant and discontinued projects.

Restless Legs Syndrome is a neurologic disorder with a core feature of a distressing, irresistible need or urge to move the legs. Risk factors for RLS include low iron levels, kidney failure, Parkinson's disease, diabetes mellitus, rheumatoid arthritis, and pregnancy.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385279-sleep-disorders-drug-development-pipeline-review-2017

Nocturia, or nocturnal polyuria, describes the excessive urination during night time. Nocturia becomes more common with age and may be symptomatic of the use of diuretic substances, prescription drugs, edema from heart failure, insomnia, pain and prostate or bladder disorders.

Finally, insomnia is a sleep disorder that is characterized by difficulty in falling or staying asleep. Symptoms include difficulty falling asleep at night, waking up during the night, irritability, depression and anxiety.

The size of these pipelines ranges from eight products in restless legs syndrome and nocturia to 31 in insomnia. Across all three of these indications there is a diverse range of molecular targets due to the different pathologies of the indications. The most common targets for restless legs syndrome, nocturia and insomnia therapeutics are D2 dopamine receptor, vasopressin V2 receptor and orexin receptor, respectively.

Scope
- Which companies are the most active within the pipeline for sleep disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of sleep disorders?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points

1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Sleep Disorders Report Coverage 7
2.2 Restless Legs Syndrome - Overview 7
2.3 Nocturia - Overview 7
2.4 Insomnia - Overview 7
3 Therapeutics Development 8
3.1 Restless Legs Syndrome 8
3.2 Nocturia 11
3.3 Insomnia 14
4 Therapeutics Assessment 21
4.1 Restless Legs Syndrome 21
4.2 Nocturia 27
4.3 Insomnia 33
5 Companies Involved in Therapeutics Development 39
5.1 Restless Legs Syndrome 39
5.2 Nocturia 42
5.3 Insomnia 44
6 Dormant Projects 53
6.1 Restless Legs Syndrome 53
6.2 Nocturia 53
6.3 Insomnia 54
7 Discontinued Products 56
7.1 Restless Legs Syndrome 56
7.2 Insomnia 56
8 Product Development Milestones 58
8.1 Restless Legs Syndrome 58
8.2 Nocturia 63
…Continued

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/sleep-disorders-pharmaceutical-and-healthcare-pipeline-review-2017/250082

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250082

More News From marketerslog.com

Gains by banks, technology firms lead US stocks higher

Oct 22, 2017

Technology companies and banks led U.S. stocks higher in late-afternoon trading Friday, placing the market on course to extend its gains for the week. Investors cheered a crop of strong company earnings. They also drew encouragement from the Senate's passage of a budget bill, a move expected to ease the path for the White House's tax cut proposal. Consumer products companies lagged the most. KEEPING SCORE: The Standard & Poor's 500 index rose 11 points, or 0.5 percent, to 2,573 as of 3:10 p.m. Eastern time. The Dow Jones industrial average gained 130 points, or 0.6 percent, to 23,293. The...

Q&A on the GOP effort to overhaul the nation's tax system

Oct 22, 2017

WASHINGTON — Divided Republicans in Congress are tackling an ambitious overhaul of the nation's tax system that would deeply cut levies for corporations and double the standard deduction used by most average Americans. Despite controlling Congress and the White House, Republicans failed to carry out their years-long promise to dismantle and replace former President Barack Obama's health care law. They say the nearly $6 trillion tax plan, to bring the first major revamp in three decades, is their once-in-a-generation opportunity. President Donald Trump sets it as his highest legislative priority. But can they deliver? What are the next steps for...

Europe's easy money taps to be tightened _ very slightly

Oct 22, 2017

FRANKFURT, Germany — The economy of the 19 countries that use the euro currency is growing ever stronger, and it's time for the European Central Bank to start telling the public how it will phase out its extraordinary stimulus measures. But rest assured: The era of easy money isn't ending just yet in Europe, say analysts. The bank will ease off its month bond-buying stimulus slowly — and interest rates likely won't be raised for nearly another two years. While ECB President Mario Draghi and other officials have said that they will decide on some aspects of stimulus withdrawal at...

Global stocks get modest boost from US tax hopes

Oct 22, 2017

LONDON — World stock markets pushed higher Friday after the passing of a budget resolution in the U.S. Senate stoked hopes that President Donald Trump's tax reform package will be enacted. KEEPING SCORE: In Europe, Germany's DAX rose 0.2 percent to 13,018 while the CAC 40 in France rose 0.1 percent to 5,375. The FTSE 100 index of leading British shares was 0.3 percent higher at 7,542. U.S. shares were poised for a solid opening with Dow futures and the broader S&P futures up 0.2 percent. US TAX PLAN: The Senate on Thursday narrowly approved the budget plan, methodically working...

Last-minute rebound lifts S&P 500, Dow edge to new highs

Oct 22, 2017

A last-minute surge nudged U.S. stock indexes mostly higher Thursday, barely extending the market's winning streak and milestone-setting run. The Standard & Poor's 500 index and Dow Jones industrial average closed higher for the fifth straight day, each posting new highs. The other indexes finished slightly lower as investors continued to pore through the latest batch of company earnings. Technology companies weighed on the market all day, but gains in health care stocks helped offset some of those losses. "You have a lot of risk assets, especially equities, having done pretty well," said Sameer Samana, global quantitative strategist for Wells...

Weather, 20 December
Houston Weather
+7

High: +11° Low: -2°

Humidity: 83%

Wind: NNE - 7 KPH

Canberra Weather
+27

High: +27° Low: +17°

Humidity: 87%

Wind: W - 20 KPH

Roissy-en-France Weather
+6

High: +6° Low: -5°

Humidity: 87%

Wind: ENE - 7 KPH

Florence Weather
+9

High: +9° Low: +6°

Humidity: 97%

Wind: ENE - 17 KPH

Parga Weather
+7

High: +16° Low: +4°

Humidity: 100%

Wind: SE - 25 KPH